Smoking cessation, harm reduction, and biomarkers protocols in the PhenX Toolkit: Tools for standardized data collection.

Addiction neuroscience Pub Date : 2023-09-01 Epub Date: 2023-04-08 DOI:10.1016/j.addicn.2023.100081
Laura Jean Bierut, Tabitha P Hendershot, Neal L Benowitz, K Michael Cummings, Robin J Mermelstein, Megan E Piper, Scott I Vrieze, Theodore L Wagener, Mark D Nelms, Cataia Ives, Deborah Maiese, Carol M Hamilton, Gary E Swan
{"title":"Smoking cessation, harm reduction, and biomarkers protocols in the PhenX Toolkit: Tools for standardized data collection.","authors":"Laura Jean Bierut, Tabitha P Hendershot, Neal L Benowitz, K Michael Cummings, Robin J Mermelstein, Megan E Piper, Scott I Vrieze, Theodore L Wagener, Mark D Nelms, Cataia Ives, Deborah Maiese, Carol M Hamilton, Gary E Swan","doi":"10.1016/j.addicn.2023.100081","DOIUrl":null,"url":null,"abstract":"<p><p>The use of standard protocols in studies supports consistent data collection, improves data quality, and facilitates cross-study analyses. Funded by the National Institutes of Health, the PhenX (consensus measures for <b>Phen</b>otypes and e<b>X</b>posures) Toolkit is a catalog of recommended measurement protocols that address a wide range of research topics and are suitable for inclusion in a variety of study designs. In 2020, a PhenX Working Group of smoking cessation experts followed a well-established consensus process to identify and recommend measurement protocols suitable for inclusion in smoking cessation and smoking harm reduction studies. The broader scientific community was invited to review and provide feedback on the preliminary recommendation of the Working Group. Fourteen selected protocols for measuring smoking cessation, harm reduction, and biomarkers research associated with smoking cessation were released in the PhenX Toolkit ( https://www.phenxtoolkit.org) in February 2021. These protocols complement existing PhenX Toolkit content related to tobacco regulatory research, substance use and addiction research, and other measures of smoking-related health outcomes. Adopting well-established protocols enables consistent data collection and facilitates comparing and combining data across studies, potentially increasing the scientific impact of individual studies.</p>","PeriodicalId":72067,"journal":{"name":"Addiction neuroscience","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11027214/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Addiction neuroscience","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.addicn.2023.100081","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/4/8 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The use of standard protocols in studies supports consistent data collection, improves data quality, and facilitates cross-study analyses. Funded by the National Institutes of Health, the PhenX (consensus measures for Phenotypes and eXposures) Toolkit is a catalog of recommended measurement protocols that address a wide range of research topics and are suitable for inclusion in a variety of study designs. In 2020, a PhenX Working Group of smoking cessation experts followed a well-established consensus process to identify and recommend measurement protocols suitable for inclusion in smoking cessation and smoking harm reduction studies. The broader scientific community was invited to review and provide feedback on the preliminary recommendation of the Working Group. Fourteen selected protocols for measuring smoking cessation, harm reduction, and biomarkers research associated with smoking cessation were released in the PhenX Toolkit ( https://www.phenxtoolkit.org) in February 2021. These protocols complement existing PhenX Toolkit content related to tobacco regulatory research, substance use and addiction research, and other measures of smoking-related health outcomes. Adopting well-established protocols enables consistent data collection and facilitates comparing and combining data across studies, potentially increasing the scientific impact of individual studies.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
PhenX 工具包中的戒烟、减少危害和生物标志物协议:标准化数据收集工具。
在研究中使用标准协议有助于数据收集的一致性、提高数据质量并促进跨研究分析。在美国国立卫生研究院的资助下,PhenX(表型和暴露的共识测量方法)工具包是一个推荐测量方案目录,涉及广泛的研究课题,适合纳入各种研究设计。2020 年,由戒烟专家组成的 PhenX 工作组遵循成熟的共识流程,确定并推荐适合纳入戒烟和减少吸烟危害研究的测量方案。更广泛的科学界受邀对工作组的初步建议进行审查并提供反馈意见。2021 年 2 月,PhenX 工具包(https://www.phenxtoolkit.org)发布了 14 个选定的戒烟、减烟危害和戒烟相关生物标志物研究测量方案。这些规程是对现有 PhenX 工具包中与烟草监管研究、药物使用和成瘾研究以及其他吸烟相关健康结果测量相关内容的补充。采用成熟的规程可实现一致的数据收集,便于比较和合并各项研究的数据,从而可能提高单项研究的科学影响力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Addiction neuroscience
Addiction neuroscience Neuroscience (General)
CiteScore
1.30
自引率
0.00%
发文量
0
审稿时长
118 days
期刊最新文献
Opioid drug seeking after early-life adversity: a role for delta opioid receptors Contents Editorial Board Corrigendum to “Xylazine is an agonist at kappa opioid receptors and exhibits sex-specific responses to opioid antagonism” [Addiction Neuroscience, Volume 11, June 2024, 100155] Neurokinin-1 receptors in the nucleus accumbens shell influence sensitivity to social defeat stress and stress-induced alcohol consumption in male mice
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1